Connect with us

Technology

NIIMBL Announces 11 New Technology, Workforce, and Global Health Fund Projects

Published

on

NEWARK, Del., April 29, 2025 /PRNewswire/ — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce 11 new member-led technology, workforce development, and Global Health Fund projects with a value of ~$11.2 million through the Institute’s Project Call 8.1. This new slate of collaborative projects addresses key industry challenges and aims to strengthen domestic biopharmaceutical manufacturing capabilities.

Six projects focus on priority technology areas identified by NIIMBL industry members, including manufacturing platforms for biopharmaceutical products, process analytical technologies, and data science and modeling.

“NIIMBL members are well-positioned to advance current state-of-the-art processes and analytical technologies,” said Sandeep Kedia, NIIMBL Senior Technology Fellow. “We are excited about the potential these projects have to advance our ability to manufacture biologic products and push the boundaries of what is possible in biomanufacturing.”

The slate of new projects also includes three workforce projects aimed at building awareness and talent pipeline development, ensuring the U.S. has the strongest biopharmaceutical workforce globally.

“To meet the industry’s future talent needs, we need to find innovative ways to reach new talent and offer them pathways to begin their careers in the industry,” said John Balchunas, NIIMBL Workforce Director. “The new projects will provide new tools to help us do that.”

The NIIMBL Global Health Fund (GHF) was established with funding contributed by the Gates Foundation to develop and implement innovative technologies to manufacture preventative medical countermeasures and biologics. Two projects funded as part of Project Call 8.1 focus on reducing the cost of goods to manufacture mRNA-based preventative medical countermeasures.

“With mRNA technologies opening the doors for new therapeutics, we are excited by the opportunities these projects provide to lower costs,” said Chris Roberts, NIIMBL Associate Institute Director.

The approximate value of these 11 projects includes NIIMBL funding plus cost share from participating organizations.

Since NIIMBL’s launch in 2017, the Institute has awarded 160 projects with a total investment of more than $134 million. NIIMBL is composed of 200+ member organizations from academia, industry, government, and non-profit organizations with a common goal to advance biopharmaceutical manufacturing. Funding for Project Call 8.1 projects is subject to project award negotiations.

For a description of each project and to learn more about NIIMBL, please visit the Project Call 8.1 page.

Project Call 8.1 List

Technology Projects

Project: Automation and Control of a Precipitation-based Continuous Downstream Process for High Titer Products
Lead: Rensselaer Polytechnic Institute
Participants: Astra Zeneca, Boehringer Ingelheim, Bristol Myers Squibb, ChromaTan, Dyadic, Janssen, Merck & Co., Inc., MilliporeSigma, PAK Bio, PendoTECH, Sanofi

Project: Rapid Bioburden and Sterility Testing for Biopharmaceutical Manufacturing
Lead: Mango, Inc.
Participant: Janssen

Project: Single Particle Analyzer for High-throughput and High-content Characterization of Nanoparticle-based RNA Therapy
Lead: Johns Hopkins University
Participants: CICS Analytics, Sartorius Stedim, National Institute of Standards and Technology (NIST)

Project: Integrating High-Throughput Chromatography and Data Science in a Platform for the Rapid and Accurate Quantification of Full, Partial, and Empty AAV Capsids
Lead: North Carolina State University
Participants: Bio Rad Laboratories, Bristol Myers Squibb, Cornell University, LigaTrap Technologies LLC, MilliporeSigma, Refeyn, Rensselaer Polytechnic Institute, Sartorius Stedim, University of Florida

Project: Obtaining Extensive At-line Input and Output Analytics Combined with Machine Learning to Improve Predictive CQA
Lead: Carnegie Mellon University
Participants: Johns Hopkins University, Merck & Co., Inc., Pfizer, Inc., University of Maryland Baltimore

Project: Spectro-acoustic Process Analytical Technology for Real-time Monitoring of Biopharmaceuticals
Lead: Purdue University
Participants: Merck & Co., Inc.

Workforce Projects

Project: Creation of National Standards for a Biomanufacturing Technician Registered Apprenticeship Program
Lead: Apprenti
Participants: InnovATEBIO, LifeScience Workforce Collaborative (LSWC)

Project: Life Sciences Career Hub: Biomanufacturing in Central Massachusetts
Lead: MassBio Education Foundation
Participants: Masschusetts Biomedical Initiative (MBI)

Project: A Day in the Life: Highlighting Careers in Biopharmaceutical Manufacturing
Lead: Bioscience Core Skills Institute (BCSI)
Participants: BioSTL, Merck & Co., Inc., Pfizer, Inc., Texas A&M Engineering Experiment Station (TEES)

Global Health Fund Projects

Project: Lowering the Cost of Goods for Making mRNA Utilizing Continuous Manufacturing
Lead: Sepragen
Participants: University of Massachusetts Lowell, University of Pennsylvania

Project: Lowering mRNA LNP Cost of Goods by Adding a Dose-sparing and Stabilizing Adjuvant
Lead: VaxForm

About NIIMBL

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness and security. NIIMBL is part of Manufacturing USA®, a network of federally sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.

Contact
News Media
Daniel Maiese
Communications Manager
302-831-3824
dmaiese@udel.edu

View original content to download multimedia:https://www.prnewswire.com/news-releases/niimbl-announces-11-new-technology-workforce-and-global-health-fund-projects-302441649.html

SOURCE National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Jtibot Showcases Autonomous Outdoor Sweeping Innovation at Interclean Amsterdam 2026, Accelerating European Market Expansion

Published

on

By

AMSTERDAM, April 24, 2026 /PRNewswire/ — Jtibot, a developer of autonomous outdoor cleaning solutions, concluded a successful showcase at Interclean Amsterdam 2026, highlighting its focus on large-scale, AI-driven sweeping for industrial, municipal, and campus environments.

At Hall 8, Booth 538, Jtibot presented its autonomous outdoor sweeper designed for environments exceeding 10,000 sqm. Positioned between traditional equipment and emerging robotics, the system addresses the growing demand for more efficient and less labor-dependent outdoor cleaning operations.

During the exhibition, Jtibot attracted strong interest from European distributors and facility management professionals seeking scalable solutions for large-area maintenance. The company was also featured in an official media interview at the event, reflecting increasing attention toward autonomous technologies in the cleaning industry.

Jtibot’s approach centers on human-machine collaboration. By reducing repetitive manual work while maintaining operational flexibility, its systems support more sustainable and efficient facility management practices. This aligns with broader ESG (Environmental, Social, and Governance) priorities, including improved resource efficiency and enhanced working conditions.

Building on its presence at Interclean, Jtibot is currently advancing discussions with multiple European partners for regional distribution and deployment. The company is also in the final stage of a fleet procurement agreement valued at approximately $1.4 million, signaling early commercial traction in large-scale applications scenarios.

“As outdoor environments continue to grow in scale and complexity, automation is becoming essential,” said Steven, VP at Jtibot. “Our goal is not to replace people, but to empower them—making operations more efficient and labor more sustainable.”

Following Interclean Amsterdam 2026, Jtibot is actively expanding its European partner network and preparing for broader market deployment across key regions, as it accelerates its global commercialization strategy.

About Jtibot
Jtibot specializes in autonomous outdoor sweepers designed for large-scale environments. By combining AI-driven navigation with industrial-grade hardware, the company enables efficient, scalable, and sustainable cleaning operations worldwide.

Photo – https://mma.prnewswire.com/media/2965027/PR_image.jpg

View original content:https://www.prnewswire.co.uk/news-releases/jtibot-showcases-autonomous-outdoor-sweeping-innovation-at-interclean-amsterdam-2026-accelerating-european-market-expansion-302752777.html

Continue Reading

Technology

2U Refinances and Raises Growth Capital

Published

on

By

ARLINGTON, Va., April 24, 2026 /PRNewswire/ — Many education technology companies spent 2024 and 2025 scaling back. New university partnerships slowed as institutions built internal capacity. Against that backdrop, 2U completed a growth recapitalization, with its existing owners putting growth capital into the business alongside a refinancing of its current credit facilities.

The question worth asking is: why now, and what did they see?

2U operates edX, a global online learning platform originally co-founded by Harvard and MIT that now reaches more than 100 million people through over 5,300 programs with 250-plus institutional and enterprise partners. Employees from more than 60% of Fortune 500 companies use edX for professional development. To date, over 76,000 people have graduated from 2U-powered degree programs from leading institutions, including UC Berkeley, Howard University, and Georgetown. The company has been privately held since completing a financial reorganization in 2024, and Kees Bol has served as CEO since January 2025.

Lincoln International, which advised 2U on the transaction exclusively, described the refinancing outcome: extended credit maturities, improved capital structure, and financial flexibility to continue executing on 2U’s long-range plan. Managing Director Alex Stevenson said the deal “reflects the confidence of 2U’s owners in the long-term value of the business.”

Confidence in what, exactly? The AI workforce training market. Skills in AI-affected roles are evolving 66% faster than average according to PwC research, and IDC has estimated that unfilled AI skills gaps could cost the global economy $5.5 trillion. Universities and enterprises are both trying to solve that problem, and both are looking for platforms with the breadth and accreditation backing to do it credibly.

2U’s partnerships are designed for exactly that. IBM’s six technical microcredentials on edX train the engineers and data scientists who build AI systems. Microsoft’s CxO Edge program, launched in late 2025, targets the C-suite executives who need to move from AI pilots to enterprise-wide adoption, part of a Microsoft presence on edX that has drawn over 40,000 learners in the past six months alone.. Oxford’s Faculty of Law program addresses governance: what board members and legal advisors need to understand about AI liability, compliance, and fiduciary responsibility. UC Berkeley’s Master of Information and Data Science (MIDS) online program prepares learners to shape the future of AI and data science with human-centered values and focuses on solving the world’s most pressing data challenges. Each program exists because a specific employer community identified a specific gap.

That’s the differentiation investors are backing. Generic online courses are abundant. Programs designed in partnership with IBM, Microsoft, UC Berkeley, and Oxford’s Faculty of Law and delivered on a platform with proven Fortune 500 adoption are not.

Credentials earned on 2U’s edX platform carry the academic standing of the issuing partner institutions. Its programs span executive education, professional certificates, microcredentials, and accredited online degree programs, all powered by 2U’s infrastructure but conferred by partner universities and institutions with their own accreditation.

HolonIQ data puts the broader trend in context: microcredentials grew from 7% of global online program offerings in 2022 to 19% by 2025. The shift toward stackable, job-aligned credentials, in addition to traditional degrees,  is real and accelerating. The global online education market is projected to exceed $200 billion as that trend matures. 2U’s decision to build depth in short-form, employer-designed AI training aligns directly with where learner demand is heading.

None of this is abstract for the organizations that use edX at scale. When a company needs to certify 500 engineers on AI development, or prepare its entire C-suite for a board presentation on AI governance, the platform’s reach and credential quality both matter. A certification backed by IBM and a degree from institutions such as Berkeley carries weight with hiring managers in a way a generic online course does not.

The refinancing extends 2U’s ability to keep building that catalog and the partnerships behind it. Stevenson framed it as giving the management team “the financial foundation to keep executing on its mission.” The mission, under Bol’s leadership, is straightforward: help universities and enterprises close the AI skills gap by meeting learners where they are, at the pace the market demands.

The investors who contributed growth capital made a bet that a platform that reaches 100 million people and has 250-plus partners, including IBM, Microsoft, UC Berkeley, and Oxford in its program portfolio, is better positioned to close that gap than any platform that would need to build from scratch.

Media Contact:
Kees Bol
social@2u.com 

Logo: https://mma.prnewswire.com/media/2965091/2U_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/2u-refinances-and-raises-growth-capital-302752776.html

Continue Reading

Technology

Autonomous Resource Corporation and Oak Ridge National Laboratory Partner to Accelerate AI-Enabled Defense Manufacturing at National Scale

Published

on

By

Strategic partnership combines ORNL’s supercomputing and advanced manufacturing expertise with ARC’s autonomous production platform to address critical defense industrial base shortfalls

OAK RIDGE, Tenn. and NEW YORK, April 24, 2026 /PRNewswire/ — Autonomous Resource Corporation (ARC), a Delaware corporation, and Oak Ridge National Laboratory (ORNL), the U.S. Department of Energy’s largest multi-program science and energy laboratory, today announced a Memorandum of Understanding (MOU) establishing a strategic public-private partnership to accelerate the on-demand manufacture of qualified, mission-critical components for U.S. national security applications.

The partnership combines ORNL’s HPC and manufacturing capability with ARC’s ARCNet distributed AI-manufacturing platform

The partnership — known as the Exascale Foundry — will combine ORNL’s computing and manufacturing capabilities with ARC’s ARCNet distributed manufacturing platform to create a closed-loop system for AI-enabled materials and manufacturing qualification and autonomous production at defense-relevant scale.

“The United States faces an urgent need to rebuild its manufacturing capacity for critical defense components,” said Bryan Wisk, CEO of ARC. “By combining ORNL’s world-leading computational, materials science, and manufacturing capabilities with our autonomous production infrastructure, we can compress manufacturing and qualification timelines from years to months and deliver manufactured parts at the volumes the warfighter needs.”

Partnership Highlights

Under the MOU, ARC will deploy advanced manufacturing equipment organized into seven production nodes connected to ORNL via ARC’s secure ARCNet infrastructure. ARC will expand capability through ORNL’s high-performance computing (HPC) resources.

ORNL will provide access to HPC expertise for simulation-driven materials characterization and qualification, along with technologies developed at the Manufacturing Demonstration Facility (MDF), the Department of Energy’s only large-scale, open-access advanced manufacturing facility. ORNL’s Peregrine AI software, which has analyzed over 1.9 million additive manufacturing layers, will be integrated into ARC’s production nodes for real-time adaptive control and quality assurance.

This partnership also supports DOE’s Genesis Mission, a national initiative to build the world’s most powerful scientific platform to accelerate discovery science, strengthen national security and drive energy innovation. ARC and ORNL’s collective capabilities will help reenvision advanced manufacturing and industrial productivity, accelerate defense production and qualification, and secure critical supply chain elements.

“ORNL’s advanced manufacturing and computing capabilities are uniquely positioned to help accelerate the transition of laboratory-proven technologies into production-scale defense manufacturing,” said Moe Khaleel, ORNL associate laboratory director for National Security Sciences. “Partnering with ARC ensures we are transitioning our research into real production outcomes.”

The initial implementation will focus on high-temperature nickel superalloy turbine components for autonomous air vehicle engines using metal binder jetting technology, directly addressing demonstrated production bottlenecks in the U.S. defense supply chain.

ORNL Chief Manufacturing Officer Craig Blue added, “This partnership exemplifies the type of relationship necessary to build and grow domestic supply chains for our national security.”

About Autonomous Resource Corporation

ARC is a New York–headquartered corporation building and operating an AI-enabled, autonomous manufacturing platform for national security and critical infrastructure applications. ARC’s Autonomous Resource Controller Network (ARCNet) connects distributed production cells into a secure, federated manufacturing grid capable of producing qualified components at scale. ARC’s leadership team brings deep experience across defense technology, capital markets, materials science, and additive manufacturing at production scale.

About Oak Ridge National Laboratory

Oak Ridge National Laboratory is the largest U.S. Department of Energy science and energy laboratory, conducting basic and applied research to deliver transformative solutions to compelling problems in energy and security. DOE’s Manufacturing Demonstration Facility at ORNL partners with more than 300 companies, spurring over $5.5 billion in economic growth. ORNL is managed by UT-Battelle, LLC for the U.S. Department of Energy’s Office of Science.

Media Contacts:

ARC: Bryan Wisk, Chief Executive Officer | bryan@autonomousresource.com | 929-523-3953

ORNL: Eric Swanson, National Security Sciences Communications Lead | swansonej@ornl.gov | 865-206-5794

View original content to download multimedia:https://www.prnewswire.com/news-releases/autonomous-resource-corporation-and-oak-ridge-national-laboratory-partner-to-accelerate-ai-enabled-defense-manufacturing-at-national-scale-302752414.html

SOURCE Autonomous Resource Corporation

Continue Reading

Trending